Cargando…

Review of quality assessment tools for the evaluation of pharmacoepidemiological safety studies

OBJECTIVES: Pharmacoepidemiological studies are an important hypothesis-testing tool in the evaluation of postmarketing drug safety. Despite the potential to produce robust value-added data, interpretation of findings can be hindered due to well-recognised methodological limitations of these studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neyarapally, George A, Hammad, Tarek A, Pinheiro, Simone P, Iyasu, Solomon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2012
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467649/ https://www.ncbi.nlm.nih.gov/pubmed/23015600 http://dx.doi.org/10.1136/bmjopen-2012-001362

Ejemplares similares

A comparison of pharmacoepidemiological study designs in medication use and traffic safety research
por: Ravera, Silvia, et al.
Publicado: (2012)

Pharmacoepidemiological safety studies in children: a systematic review
por: Osokogu, Osemeke U., et al.
Publicado: (2016)

Individual mortality information in the German Pharmacoepidemiological Research Database (GePaRD): a validation study using a record linkage with a large cancer registry
por: Langner, Ingo, et al.
Publicado: (2019)

Pharmacovigilance and Pharmacoepidemiology
Publicado: (2008)

Understanding pharmacoepidemiology
Publicado: (2011)

Pharmacoepidemiology: An Overview
por: Sabaté, Mònica, et al.
Publicado: (2023)

The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology
por: Romanelli, Robert J., et al.
Publicado: (2021)

Evaluation of Medication-mediated Effects in Pharmacoepidemiology
por: Tchetgen Tchetgen, Eric J., et al.
Publicado: (2017)

Quality of reporting of drug exposure in pharmacoepidemiological studies
por: Hempenius, Mirjam, et al.
Publicado: (2020)

How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools
por: D'Andrea, Elvira, et al.
Publicado: (2021)

43. A Pharmacoepidemiologic Evaluation of Echinocandin Use
por: Jo, Jinhee, et al.
Publicado: (2020)

Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects
por: Pariente, Antoine, et al.
Publicado: (2021)

Triangulation of pharmacoepidemiology and laboratory science to tackle otic quinolone safety
por: Winterstein, Almut G., et al.
Publicado: (2021)

Registry of Senior Australians (ROSA): integrating cross-sectoral information to evaluate quality and safety of care provided to older people
por: Inacio, Maria C, et al.
Publicado: (2022)

Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 2–Comparison of the Performance of Artificial Intelligence and Traditional Pharmacoepidemiological Techniques
por: Sessa, Maurizio, et al.
Publicado: (2021)

eHealth tools to assess neurological function: a systematic review protocol for a mapping exercise
por: Ferreira, Vasco Ribeiro, et al.
Publicado: (2022)

The Promotion of Data Sharing in Pharmacoepidemiology
por: Sethi, Nayha
Publicado: (2014)

Editorial: Women in pharmacoepidemiology: 2021
por: Lopes, Luciane Cruz, et al.
Publicado: (2023)

The readability of online breast cancer risk assessment tools
por: Cortez, Sarah, et al.
Publicado: (2015)

Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist
por: Crescioli, Giada, et al.
Publicado: (2022)

Case-Only Designs in Pharmacoepidemiology: A Systematic Review
por: Nordmann, Sandra, et al.
Publicado: (2012)

Concepts of Designing and Implementing Pharmacoepidemiology Studies on the Safety of Systemic Treatments in Dermatology Practice
por: Schneeweiss, Sebastian, et al.
Publicado: (2023)

Assessing the quality, efficiency and usefulness of the Western Australian population-based Intellectual Disability Exploring Answers (IDEA) surveillance system: a surveillance system evaluation
por: Strobel, Natalie A, et al.
Publicado: (2019)

Pharmacoepidemiological aspects of outpatient pain medication
por: Zebedin, Eva-Maria, et al.
Publicado: (2011)

The Challenges and Opportunities of Pharmacoepidemiology in Bone Diseases
por: Alarkawi, Dunia, et al.
Publicado: (2018)

Cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data: a cohort study
por: Williams, Rachael, et al.
Publicado: (2018)

A pilot study to develop assessment tools for Group A Streptococcus surveillance studies
por: Pickering, Janessa, et al.
Publicado: (2023)

Pharmacoepidemiological Evaluation in Prostate Cancer—Common Pitfalls and How to Avoid Them
por: Siltari, Aino, et al.
Publicado: (2021)

Application of the urban exposome framework using drinking water and quality of life indicators: a proof-of-concept study in Limassol, Cyprus
por: Andrianou, Xanthi D., et al.
Publicado: (2019)

Assessing bias in osteoarthritis trials included in Cochrane reviews: protocol for a meta-epidemiological study
por: Hansen, Julie B, et al.
Publicado: (2014)

Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis‡
por: Xue, Fei, et al.
Publicado: (2013)

Real-World Assessment of the Impact of Erectile Dysfunction on Sexual Planning Behavior and Health- and Treatment-Related Outcomes Among Men in 8 Countries
por: Goldstein, Irwin, et al.
Publicado: (2020)

Pharmacoepidemiology in Japan: medical databases and research achievements
por: Tanaka, Shiro, et al.
Publicado: (2015)

Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
por: Mahaux, Olivia, et al.
Publicado: (2015)

Power calculator for instrumental variable analysis in pharmacoepidemiology
por: Walker, Venexia M, et al.
Publicado: (2017)

Adverse reaction signal detection methodology in pharmacoepidemiology
por: Stricker, Bruno H.
Publicado: (2018)

Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research
por: Pang, Menglan, et al.
Publicado: (2016)

Incidence in pharmacoepidemiology—Basic definitions and types of misclassification
por: Hoffmann, Mikael, et al.
Publicado: (2022)

iPrevent(®): a tailored, web-based, decision support tool for breast cancer risk assessment and management
por: Collins, Ian M., et al.
Publicado: (2016)

Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine
por: Dranitsaris, George, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_om13dkrqpdukk6us48p55cg005